When `catastrophic' is applied as an adjective to the antiphospholipid syndrome, it implies a characteristic presentation due to predominantly small blood vessel thrombosis leading to rapidly progressive failure of multiple organs and a frequently fatal outcome. We present the case of a 48year-old woman who presented with the `catastrophic' antiphospholipid syndrome without previous history of coagulation disorder or connective tissue disease that illustrates the difficulties in diagnosing and managing this disorder. We also review the factors that have been reported to have a role in the development of this condition and show how this case throws light on its pathogenesis.
Wilson WA , Gharavi AE , Koike T et al. International concensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop . Arthritis Rheum1999; 42: 1309–1311 .
2.
Asherson RA , Khamashta MA , Ordi-Ros J et al. The `primary' antiphospholipid syndrome: major clinical and serological features . Medicine1989; 68: 366–374 .
3.
Asherson RA , Cervera R , Piette JC et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients . Medicine1998; 77: 195–207 .
4.
Alarcon-Segovia D . On the catastrophic adjective for the antiphospholipid syndrome . Clin Exp Rheumatol1993; 11: 587–588 .
5.
Asherson RA . The catastrophic antiphospholipid syndrome . J Rheumatol1992; 19: 508–512 .
6.
Asherson RA , Morgan SH , Harris EN et al. Arterial occlusion causing large bowel infarction in SLE? Reflection of clotting diathesis . Clin Rheumatol1986; 5: 102–106 .
7.
Cappell MS . Esophageal necrosis and perforation associated with the anticardiolipin antibody syndrome . Am J Gastroenterol1994; 89: 1241–1245 .
8.
Asherson RA , Khamashta MA , Hughes GRV . The hepatic complications of the antiphospholipid antibodies . Clin Exp Rheumatol1991; 9: 341–344 .
9.
Zochodne D , Bolton C , Wells G et al. Critical illness polyneuropathy . Brain1987; 110: 819–825 .
10.
Golstein M , Meyer O , Bourgeois P et al. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies . Clin Exp Rheumatol1993; 11: 373–379 .
11.
Brey RL , Escalante A . Neurological manifestations of antiphospholipid antibody syndrome . Lupus1998; 7 (Suppl 2): 67–74 .
12.
Cuadrado MJ , Khamashta MA , Ballesteros A et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature . Medicine2000; 79: 57–68 .
13.
Harris EN , Pierangeli SS , Gharavi AE . Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests . Lupus1998; 7 (Suppl 2): 144–148 .
14.
McNeil HP , Simpson RJ , Chesterman CN et al. Antiphospholipid antibodies are directed against a complex antigen that includes a lipidbinding inhibitor of coagulation: b2-glycoprotein 1 (apolipiprotein H) . Proc Natl Acad Sci USA1990; 87: 4120–4124 .
15.
Galli M , Comfurius P , Maassen C et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor . Lancet1990; 335: 1544–1547 .
16.
Matsuura E , Igarashi Y , Yasuda T et al. Anticardiolipin antibodies recognize b2-glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface . J Exp Med1994; 179: 457–462 .
17.
Roubey RAS , Eisenberg RA , Winfield JB . `Anticardiolipin' autoantibodies recognize b2 glycoprotein 1 in the absence of phospholipid. Importance of antigen density and bivalent binding . J Immunol1994; 154: 954–960 .
18.
Day HM , Thiagarajan P , Ahn C et al. Autoantibodies to b2glycoprotein 1 in systemic lupus erythematosus and primary antiphospholipid syndrome: clinical correlations in comparison with other antiphospholipid antibody tests . J Rheumatol1998; 25: 667–674 .
19.
Guerin J , Feighery C , Sim RB et al. Antibodies to b2glycoprotein 1, a specific marker for the antiphospholipid syndrome . Clin Exp Immunol1997; 109: 304–309 .
20.
Drenkard C , Sanchez-Guerrero J , Alarcon-Segovia D . Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus . J Rheumatol1989; 16: 614–617 .
21.
Kitchens CS . Thrombotic storm: when thrombosis begets thrombosis . Am J Med1998; 104: 381–384 .
22.
Koffler D, Agnello V , Kunkel HG . Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus . Am J Pathol1974; 74: 109–123 .
23.
Maddison P , Reichlin M . Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus . Arthritis Rheum1979; 22: 858–863 .
24.
Gomez-Pacheco L , Villa AR , Drenkard C et al. Serum anti-b2glycoprotein 1 and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients . Am J Med1999; 106: 417–423 .
25.
Shoenfeld Y , Ziporen I . Lessons from experimental APS models . Lupus1998; 7 (Suppl 2): 158–161 .
26.
Asherson RA . The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment . Lupus1998; 7 (Suppl 2): 55–62 .
27.
Asherson RA , Shoenfeld Y . The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry?J Rheumatol2000; 27: 12–14 .
28.
Goldstein R , Moulds JM , Smith CD et al. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus . J Rheumatol1996; 23: 1173–1179 .
29.
Le Tonqueze M , Salozhin K , Dueymes M et al. Role of b2glycoprotein 1 in the antiphospholipid antibody binding to endothelial cells . Lupus1995; 4: 179–186 .
30.
Rojas-Rodriguez J , Garcia-Carrasco M , Ramos-Casal SM et al. Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients . J Rheumatol2000; 27: 238–240 .
31.
Golden BD , Belmont HM . The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al . Arthritis Rheum1998; 41: 751–752 .
32.
Dosekun AK , Pollak VE , Glas-Greenwalt P et al. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects . Arch Intern Med1984; 144: 37–42 .
